Cargando…

Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy

Epigenetic aberrations offer dynamic and reversible targets for cancer therapy; increasingly, alteration via overexpression, mutation, or rearrangement is found in genes that control the epigenome. Such alterations suggest a fundamental role in carcinogenesis. Here, we consider three epigenetic mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakopovic, Marko, Thomas, Anish, Balasubramaniam, Sanjeeve, Schrump, David, Giaccone, Giuseppe, Bates, Susan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793201/ https://www.ncbi.nlm.nih.gov/pubmed/24130964 http://dx.doi.org/10.3389/fonc.2013.00261

Ejemplares similares

Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States
por: Thomas, Anish, et al.
Publicado: (2015)

Epigenetic Therapy in Lung Cancer
por: Liu, Stephen V., et al.
Publicado: (2013)

Challenges in Cancer Molecular Targets and Therapeutics
por: Wang, Yisong, et al.
Publicado: (2011)

Pre-Clinical Studies of Epigenetic Therapies Targeting Histone Modifiers in Lung Cancer
por: Huffman, Kenneth, et al.
Publicado: (2013)

MYCN and the epigenome
por: He, Stanley, et al.
Publicado: (2013)

Epigenetic Therapy in Lung Cancer – Role of microRNAs
por: Rothschild, Sacha I.
Publicado: (2013)

Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity
por: Wachowska, Malgorzata, et al.
Publicado: (2015)

Grand Challenges in Oncology
por: Giaccone, Giuseppe
Publicado: (2011)

In Memory of Professor John Gordon McVie: Bringing People Together 13 January 1945 – 20 January 2021
por: Giaccone, Giuseppe
Publicado: (2021)

Epigenetic Targeting of Glioblastoma
por: Romani, Massimo, et al.
Publicado: (2018)

Racial disparities in liver cancer: Evidence for a role of environmental contaminants and the epigenome
por: Vidal, Adriana C., et al.
Publicado: (2022)

Challenges in Diversity, Equity, and Inclusion in Research and Clinical Oncology
por: El-Deiry, Wafik S., et al.
Publicado: (2021)

Therapeutic Targeting of Cancer: Epigenetic Homeostasis
por: Yu, Xiaoyuan, et al.
Publicado: (2021)

Developmental Epigenetics: Phenotype and the Flexible Epigenome
por: John, Rosalind M., et al.
Publicado: (2018)

Editorial: Insights in epigenomics and epigenetics: 2022
por: Ruden, Douglas M., et al.
Publicado: (2023)

Successful generation of epigenetic disease model mice by targeted demethylation of the epigenome
por: Horii, Takuro, et al.
Publicado: (2020)

A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer
por: Subramaniam, Deepa S., et al.
Publicado: (2018)

Novel Treatments for Thymoma and Thymic Carcinoma
por: Rajan, Arun, et al.
Publicado: (2015)

Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)
por: Momparler, Richard L.
Publicado: (2013)

Epigenome Engineering in Cancer: Fairytale or a Realistic Path to the Clinic?
por: Falahi, Fahimeh, et al.
Publicado: (2015)

Editorial: Genomics and Epigenomics of Cancer Immunotherapy: Challenges and Clinical Implications
por: Abedalthagafi, Malak
Publicado: (2021)

Editorial: Implementation of genomic and epigenomic innovation in clinical cancer diagnostics
por: Schenkel, Laila C., et al.
Publicado: (2023)

A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer
por: Kim, Chul, et al.
Publicado: (2021)

The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
por: De Smedt, Eva, et al.
Publicado: (2018)

Editorial: The roles of genome and epigenome in poorly studied male-specific cancers
por: Na, Rong, et al.
Publicado: (2023)

Expanded CAG/CTG repeats resist gene silencing mediated by targeted epigenome editing
por: Yang, Bin, et al.
Publicado: (2021)

Brave new epigenomes: the dawn of epigenetic engineering
por: Köferle, Anna, et al.
Publicado: (2015)

Entering the post-epigenomic age: back to epigenetics
por: Bultmann, Sebastian, et al.
Publicado: (2018)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Epigenetic Targets in Synovial Sarcoma: A Mini-Review
por: Hale, Ryland, et al.
Publicado: (2019)

Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology
por: Cuyàs, Elisabet, et al.
Publicado: (2021)

A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression
por: Herbst, Roy, et al.
Publicado: (2021)

An epigenomic approach to therapy for tamoxifen-resistant breast cancer
por: Feng, Qin, et al.
Publicado: (2014)

Targeted Therapies and Biomarkers in Small Cell Lung Cancer
por: Taniguchi, Hirokazu, et al.
Publicado: (2020)

The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects
por: Singh, Reema, et al.
Publicado: (2021)

Expanding Roles for CD4 T Cells and Their Subpopulations in Tumor Immunity and Therapy
por: Dobrzanski, Mark J.
Publicado: (2013)

Editorial: It takes a village: The expanding multi-disciplinary approach to brain metastasis
por: Fecci, Peter E., et al.
Publicado: (2022)

Epigenome environment interactions accelerate epigenomic aging and unlock metabolically restricted epigenetic reprogramming in adulthood
por: Treviño, Lindsey S., et al.
Publicado: (2020)

Lung Cancer Screening and Epigenetics in African Americans: The Role of the Socioecological Framework
por: Watson, Karriem Sadot, et al.
Publicado: (2019)

Targeting the epigenome: effects of epigenetic treatment strategies on genomic stability in healthy human cells
por: Purrucker, Jan C., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m58pa6pef0711lf9fa5eqrhhrl